Yale Jen
Stock Analyst at Laidlaw & Co.
(n/a)
# 4,226
Out of 4,873 analysts
15
Total ratings
8.33%
Success rate
-51.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNTI Senti Biosciences | Initiates: Buy | $5 | $1.99 | +151.26% | 1 | Jun 6, 2025 | |
| ICAD iCAD, Inc. | Downgrades: Hold | n/a | $3.71 | - | 1 | Apr 17, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $85.14 | +23.33% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $7.89 | +140.96% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.59 | +1,582.09% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $6.74 | +612.17% | 1 | Jul 29, 2024 | |
| MEIP MEI Pharma | Downgrades: Hold | n/a | $2.31 | - | 1 | Jul 23, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.49 | +5,032.35% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $2.15 | +10,365.12% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $4.01 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.61 | +1,527.07% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.49 | - | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $2.32 | +10,245.27% | 1 | Sep 6, 2022 |
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.99
Upside: +151.26%
iCAD, Inc.
Apr 17, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.71
Upside: -
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $85.14
Upside: +23.33%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $7.89
Upside: +140.96%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.59
Upside: +1,582.09%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $6.74
Upside: +612.17%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.31
Upside: -
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.49
Upside: +5,032.35%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.15
Upside: +10,365.12%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.01
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.61
Upside: +1,527.07%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.49
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $2.32
Upside: +10,245.27%